Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to understand, with the use of functional magnetic resonance
imaging, the neural correlates involved in appetite control and the mechanism of weight gain
in patients with schizophrenia treated with atypical antipsychotics. We hypothesize that a
difference in cerebral activations between weight gaining and non-weight gaining patients
will be detected after four months of treatment with olanzapine.
Phase:
Phase 4
Details
Lead Sponsor:
Université de Montréal
Collaborators:
Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal Centre de recherche Fernand-Seguin, Hôpital Louis-H. Lafontaine Eli Lilly and Company Hopital du Sacre-Coeur de Montreal